Scott Ogg
Geschäftsführer bei ARMO BIOSCIENCES INC
Profil
Scott Ogg is currently the Vice President of Operations & Development at ARMO BioSciences, Inc. Prior to this, he worked as the Director of Project & Portfolio Management at Gilead Sciences, Inc. and as the Director of Project & Alliance Management at Arresto BioSciences, Inc. He also held positions at Nektar Therapeutics and Exelixis, Inc. as an Associate Director of Program Management and Associate Director of Research, respectively.
Dr. Ogg received his undergraduate degree from Albion College and his doctorate from Tufts University.
Aktive Positionen von Scott Ogg
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMO BIOSCIENCES INC | Geschäftsführer | 01.05.2013 |
Ehemalige bekannte Positionen von Scott Ogg
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.04.2013 |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Corporate Officer/Principal | 01.01.2011 |
Gilead Sciences International Ltd.
 Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Ausbildung von Scott Ogg
| Tufts University | Doctorate Degree |
| Albion College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| EXELIXIS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Gilead Sciences International Ltd.
Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Consumer Services |
